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During	 the	 last	 20	 years,	 the	 cutaneous	 administration	 of	 active	 principles	 has	 been	
taking	a	key	role	not	only	for	the	possibility	to	achieve	high	skin	drug	concentrations	for	
the	 treatment	 of	 local	 pathologies,	 but	 also	 for	 reaching	 therapeutic	 plasmatic	
concentrations	 for	 systemic	 administration.	 In	 the	 field	 of	 cutaneous	 delivery,	 film-




rheological	behavior	of	 these	pharmaceutical	dosage	 forms,	 are	 still	 scarcely	 studied	
since	most	of	the	research	is	overlooking	their	importance	dealing	with	drug	delivery,	
pharmacokinetic	 and	 safety	 evaluation.	 Hence,	 there	 is	 the	 need	 to	 study	 the	most	
relevant	 issues	 involved	 in	 the	design	of	 both	 film-forming	 systems	and	 transdermal	
patches	 and	 clarify	 the	 possible	 relationships	 between	 rheological	 pattern,	 adhesive	
properties	and	in	vitro	biopharmaceutical	performances.	This	kind	of	relationship	could	
provide	 useful	 information	 to	 design	 and	 optimize	 both	 film-forming	 systems	 and	
transdermal	patches.		
	
This	doctoral	 thesis	aimed	to	evaluate	the	effect	of	 the	 formulation	compositions	on	
rheological,	 adhesive	 and	 mechanical	 properties	 as	 well	 as	 on	 the	 in	 vitro	













characteristics;	 moreover,	 the	 main	 technological	 and	 in	 vitro	 biopharmaceutical	
properties	were	tested;	
(3) the	 design	 of	 transdermal	 patches	 based	 on	 a	 styrenic	 copolymer	 (styrene-block-
(ethylene-co-butylene)-block-styrene,	 SEBS);	 the	 effects	 of	 SEBS	 and	 tackifiers	
molecular	 weights	 on	 the	 rheological	 and	 adhesive	 properties	 were	 investigated.	 In	
particular,	the	debonding	behavior	under	different	operative	conditions	was	evaluated	

























The	 relevance	 of	 transdermal	 dosage	 forms	 is	 due	 to	 the	 possibility	 to	 obtain	 a	









resulting	 ultimately	 in	 an	 in	 situ	 formation	 of	 a	 polymeric	 film.	 Since	 this	 allows	 a	
significant	 quantitative	 change	 in	 the	 composition	of	 the	 film,	 usually	 a	 plasticizer	 is	
added	to	overcome	the	brittleness	of	the	final	film	[1].	





matrix	 and	 reservoir	 types.	 Among	 the	 matrix	 platforms,	 drug-in-adhesive	 systems	
consist	 of	 an	 adaptable	 backing	 layer,	 an	 adhesive	 matrix,	 in	 which	 the	 active	
substance(s)	 is	 dissolved	or	dispersed,	 and	a	 removable	 release	 liner.	 These	 systems	
allow	to	improve	patient’s	compliance	because	they	are	thin,	flexible,	comfortable	and	















the	 stratum	 corneum.	 Therefore,	 to	 assure	 a	 prolonged	 permeation	 of	 the	 active	
substance(s)	through	the	skin,	a	whole	contact	between	the	dosage	form	and	the	intact	
delivery	surface	for	the	entire	treatment	period	is	critical	[7].	A	strongly	adhesion	of	the	
dosage	 form	 to	 the	 skin	 determines	 drug	 delivery,	 therapeutic	 effects	 and	 patient	
compliance	[8].	







formulation	would	 be	 fast	 drying	 (i.e.	 in	 vivo	 a	 drying	 time	 lower	 than	 5	minutes	 is	
mandatory)	 and	 the	 minimum	 film-forming	 temperature	 should	 be	 below	 the	 skin	






proper	 skin/dosage	 form	 contact,	 the	 in	 situ	 formed	 film	 should	 present	 a	 glass	
transition	 temperature	 below	 than	 the	 skin	 surface	 temperature	 (32	 °C).	 Usually,	 a	







Regarding	 TP,	 the	 adhesion	 is	 guaranteed	 by	 the	 so-called	 “pressure-sensitive	
adhesives”	(PSAs),	that	are	the	main	components	of	a	drug-in-adhesive	patch.	They	are	




rise	 to	 the	 initial	adhesion	of	 the	patch	to	 the	skin	under	 light	pressure	and	on	brief	
contact.	Since	patients	usually	apply	the	patch	slowly	and	with	accuracy,	low	tack	values	
are	desired.	Shear	adhesion	represents	the	resistance	of	the	PSA	to	flow	and	provides	

















able	 to	 adhere	 to	 skin.	 Usually,	 the	 addition	 of	 compatible	 excipients,	 such	 as	






and	more	 flexible	 [15].	 Plasticizers	 are	 low-molecular	 weight	molecules	 that	 reduce	
polymer-polymer	 chain	 secondary	 bonding	 (e.g.	 hydrogen	 bonding),	 forming	 instead	
secondary	 bonds	 with	 the	 polymer	 chains	 [16].	 Obviously,	 the	 plasticizer	 has	 to	 be	
compatible	with	 the	polymer	 and	 the	other	 components	of	 the	 formulation	and	 the	
optimization	 of	 its	 concentration	 is	 a	 crucial	 factor.	 The	 plasticizer	 concentration	
influences	the	Tg	reduction	and,	therefore,	the	characteristic	of	the	final	matrix	(e.g.	the	
higher	 the	 plasticizer	 concentration,	 the	 higher	 the	 reduction	 in	 the	 polymer	 glass	
transition	 temperature).	 Furthermore,	 according	 to	 the	 free	 volume	 theory	 [17],	 the	
higher	the	glass	transition	value,	the	lower	the	mobility	of	the	PSA	and	thus	the	lower	
the	 drug	 release	 rate	 [18].	 It	 is	 clear	 that	 the	 amount	 of	 such	 substance	 must	 be	
optimized	 to	 obtain	 matrices	 with	 the	 desired	 characteristics:	 a	 lower	 amount	 of	
plasticizer	 allows	 to	 produce	 flexible,	 but	 non-sticky	 films,	 while	 increasing	 its	
concentration	 sticky	 polymeric	 matrix	 can	 be	 produced.	 Despite	 that,	 matrices	








frequency	 the	 elastic	 modulus	 prevails	 on	 the	 viscous	 one,	 denoting	 a	 solid-like	
behavior.	The	extent	of	viscoelasticity	is	crucial	in	order	to	relax	stresses,	easily	create	a	
molecular	 contact	 and	 dissipate	 energy	 upon	 debonding	 and	 it	 is	 strictly	 related	 to	
adhesive	properties	of	a	patch,	as	referred	to	bond	formation	as	well	as	bond	separation	




100	and	1000	 rad/s)	 can	be	 related	 to	 the	peeling	process	 [20].	As	a	matter	of	 fact,	
during	the	bonding	phase	(tack),	the	adhesive	matrix	should	behave	like	a	viscous	liquid	
to	favor	its	spreading	onto	the	skin	and	to	form	good	molecular	contact	under	a	lightly	
applied	pressure.	Conversely,	during	the	debonding	process	 from	the	skin	 (peel),	 the	
adhesive	 should	 behave	 like	 a	 cohesive	 solid	 to	 ensure	 complete	 removal	 without	
leaving	any	residue	[21].	Furthermore,	a	patch	should	remain	attached	to	the	skin	for	
the	entire	 treatment	period,	 it	 should	not	present	 an	overspreading	of	 the	adhesive	
matrix	beyond	the	boundaries	and	it	should	not	leave	any	residues	upon	removal.	The	




(Dahlquist	 criterion)	 [22].	Materials	with	 elastic	moduli	 exceeding	 this	 criterion	have	





strongly	 dependent	 on	 the	 rheological	 properties	 of	 the	 PSA	 [19].	 Indeed,	 the	
viscoelastic	 characteristics	 of	 a	 PSA	 control	 its	 deformation	 and	break	 of	 fibrils	 [23].	
Regarding	TP,	two	mains	failure	mechanisms	can	occur,	namely	adhesive	and	cohesive	
failures.	 The	 first	 one	 occurs	 at	 the	 interface	 between	 the	 adhesive	 layer	 and	 the	






Generally,	 transdermal	 route	 of	 administration	 is	 limited	 to	 drugs	 with	 peculiar	















The	 release	 profiles	 of	 an	 active	 substance	 from	 a	 polymeric	 matrix	 depend	 on	 its	
diffusion	within	the	matrix	itself	[25].	The	mobility	of	the	polymer	chains	and,	therefore,	
the	grade	of	viscoelasticity	result	a	key	factor	influencing	the	drug	release	rate	[18].	In	
particular,	 a	 more	 liquid	 character	 of	 the	 formulation	 can	 weaken	 the	 interaction	
between	the	polymer	chains	and	expand	the	free	volume,	thus	resulting	in	a	faster	drug	
release	[26].		
Moreover,	 the	 possible	 interaction	 between	 the	 drug	 and	 the	 polymeric	 matrix	 is	
considered	the	main	factor	influencing	the	drug	skin	permeation	[27].	In	the	case	of	FFS,	
both	the	evaporation	rate	of	the	vehicle	and	the	thermodynamic	activity	of	the	drug	
influence	 the	 theoretical	 amount	 of	 drug	 that	 can	 permeate	 the	 skin.	 It	 is	 generally	
recognized	 that	 drug	 supersaturation	 in	 topical	 dosage	 forms	 can	 improve	 the	
permeation	 of	 the	 drug	 itself.	 In	 supersaturated	 formulations,	 the	 thermodynamic	
activity	of	the	drug	is	increased,	thus	enhancing	the	skin	penetration	[28].	On	the	other	
hand,	 supersaturated	 formulations	are	 thermodynamically	 instable,	 causing	 the	drug	
crystallization	over	time,	which	reduces	its	bioavailability	for	the	partition	through	the	
skin	[29].	Since	FFS	become	supersaturated	after	dose	actuation,	they	are	transiently	







authors	 that	 polymethacrylate	 copolymers	 can	 be	 potentially	 used	 as	 crystallization	
inhibitors	in	monolayer	patches	containing	ibuprofen	[30]	and	that	they	can	be	used,	
when	opportunely	plasticized,	as	PSA	to	develop	suitable	TP	[31].	
In	 addition	 to	 the	 functional	 features	 described	 above,	 there	 are	 other	 factor	 to	 be	
considered	 in	 the	 selection	 and	 use	 of	 a	 polymer	 for	 designing	 both	 TP	 and	 FFS.	 In	
particular,	 biocompatibility	 and	 acceptable	 regulatory	 status	 must	 be	 satisfied.	 The	
excipients	should	be	compatible	and	mixable	in	the	overall	formulation	and	the	entire	
system,	namely	polymer(s)	and	excipient(s),	should	be	biologically	inert,	non-irritating	
and	 non-sensitizing	 to	 the	 skin,	 and	 have	 no	 toxicity.	Moreover,	 the	 system	 should	
present	good	resistance	against	water	and	humidity	and	avoid	an	excessive	occlusion	of	
the	skin.	
My	 PhD	project	was	 focused	 on	 the	 study	 of	 two	polymers:	 a	 poly(ethylacrylate-co-
methylmethacrylate-co-trimethylammonioethylmethacrylate	chloride)	belonging	to	the	





name	 of	 Eudragit®	 RL	 PO	 (EuRL),	 able	 to	 deliver	 several	 drugs	 has	 been	 already	
described,	 their	 characterization	 in	 terms	 of	 mechanical	 behavior	 and	 adhesive	




to	 better	 clarify	 their	 influence	 of	 such	 variables	 on	 the	 final	 characteristics	 of	 the	
formulated	 dosage	 forms.	 Relationships	 among	 the	 mechanical	 and	 rheological	





a	 polymer	with	 completely	 different	 physico-chemical	 and	 structural	 properties	was	
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solvent	 mixtures	 (acetone	 and	 isopropanol	 in	 the	 range	 from	 10:90	 to	 40:60	 v/v),	
polymer	 concentrations	 (10-30	 %	 w/w),	 and	 plasticizer	 types	 and	 concentrations	
(triacetin	or	tributyl	citrate,	up	to	50%	of	EuRL)	were	evaluated.	EuRL	dissolved	in	80/20	




corneum	 (55	 MPa).	 The	 optimized	 formulations	 were	 able	 to	 sustain	 the	 skin	
permeation	of	ibuprofen,	ketoprofen	and	flurbiprofen	and	evidenced	the	importance	of	
each	 formulative	 variable.	 In	 particular,	 relatively	 slow	 solvent	 evaporation	 rate	 can	
determine	an	initial	“burst”	effect	and	can	influence	the	drug	permeation	in	the	initial	






















comprises	 a	 film-forming	 polymer	 dissolved	 in	 a	 volatile	 and	 skin	 tolerated	 solvent.	
When	 they	 are	 applied	 and/or	 sprayed	on	 the	 surface	 of	 the	 skin,	 the	 rapid	 solvent	
evaporation	 leads	 to	 the	 formation	 of	 a	 polymeric	 film	 in	 situ	 [2].	 The	 potential	




















it	was	 compared	 to	another	widely	used	 film	 forming	material,	namely	hydroxyethyl	
cellulose.	 As	 an	 example,	 the	 skin	 permeability	 of	 estradiol	 from	 EuRL	 based	 films	
resulted	 significantly	 lower	 than	 that	 obtained	 with	 the	 cellulose	 ether	 [11].	
Nevertheless,	the	use	of	EuRL	allowed	to	overcome	the	mechanical	issues	associated	to	
films	made	of	 hydroxyethyl	 cellulose.	 Indeed,	 it	was	 demonstrated	 that	 both	 tensile	
strength	 and	 percent	 elongation	 at	 break	 of	 the	 films	 were	 improved	 by	 mixing	 in	
appropriate	 ratio	 cellulose	 and	 EuRL	 [12].	 However,	 a	 systematic	 study	 of	 the	
formulation	variables,	namely	solvent	composition,	polymer	concentration,	nature	and	
amount	of	plasticizers,	on	the	FFS	properties	is	still	lacking.		
The	 current	 work	 aimed	 to	 study	 the	 effect	 of	 formulation	 compositions	 on	
technological	and	biopharmaceutical	properties	of	FFS	based	on	EuRL	solubilized	 in	a	

















EudragitÒ	 RL	 PO	 (poly(ethyl	 acrylate-co-methyl	 methacrylate-co-
trimethylammonioethyl	 methacrylate	 chloride);	 molar	 proportions	 of	 the	 monomer	
units	1:2:0.2;	weight	average	molar	mass	32	kDa,	EuRL)	was	kindly	supplied	by	Rofarma	
Italia	(Italy).	Tributyl	citrate	(TBC)	and	triacetin	(TRI)	were	provided	by	Morflex	(USA)	and	
Sigma	Aldrich	 (Italy),	 respectively.	 Isopropanol	 and	acetone	were	purchased	by	VWR	














The	 preliminary	 screening	 of	 placebo	 compositions	 was	 carried	 out	 keeping	 in	
consideration	the	FFS	drying	time,	the	stickiness	and	cosmetic	attributes	of	the	formed	
film.	Briefly,	a	small	volume	of	the	formulations	was	applied	with	a	micropipette	onto	a	
plastic	 liner	and	 the	 solvent	was	allowed	 to	evaporate	 to	 form	 the	 film.	The	applied	
volume	was	fixed	at	35	µL/2.5	cm2	as	this	amount	is	small	enough	to	be	applied	without	





film	 surface.	 This	 approach	 has	 been	 selected	 since	 the	 other	 method	 reported	 in	






the	glass	 transition	temperature	 (Tg)	of	 films	made	by	casting	a	polymeric	mixture	 in	
isopropyl	alcohol,	containing	the	selected	plasticizer	in	different	ratios,	was	evaluated	















were	 immersed	 in	 water	 of	 60	 °C	 for	 60	 s	 according	 to	 an	 internal	 protocol	 [15].	
Afterwards,	the	epidermis	was	carefully	removed	from	the	underlying	tissue	with	the	
help	of	 forceps	and	visually	 inspected	for	defects.	Then,	 the	epidermis	samples	were	
incubated	for	24	h	at	37	°C	in	a	0.1%	w/v	trypsin	solution	in	pH	7.4	phosphate	buffer	























































frequency:	 100	 Hz;	 Agilent	 4263B	 LCR	 Meter,	 Microlease,	 Italy).	 Samples	 with	 an	


















The	 cumulative	amount	permeated	 through	 the	 skin	per	unit	of	 area	was	 calculated	






The	drug	 concentrations	 in	 the	 receiving	media	were	determined	by	HPLC	assay	 (HP	
1100,	Chemstation,	Hewlett	Packard,	USA).	The	following	chromatographic	conditions	
were	used:	Column:	HyperCloneTM	5µm	BDS	C18	130,	150´4.6	mm	(Phenomenex,	USA);	






















































100	 -	 -	 63	±	1	
90	 10	 -	 43	±	4	
80	 20	 -	 27	±	1	
70	 30	 -	 19	±	1	
60	 40	 -	 -20	±	1	
50	 50	 -	 -26	±	2	
90	 -	 10	 40	±	2	
80	 -	 20	 18	±	1	
70	 -	 30	 13	±	2	
60	 -	 40	 -7	±	5	











































































































































































was	 comparable,	 independently	 of	 the	 technique.	 However,	 in	 the	 cited	 work	 the	
adhesive	properties	were	not	 taken	 in	 consideration.	Our	 results	 suggest	 that	 in	 the	
formulation	of	a	FFS	three	different	techniques,	namely	DSC,	probe	tack	test	and	tensile	






















































































































































result	 could	 be	 explained	 on	 the	 basis	 of	 the	mechanism	 of	 drug	 deposition	 from	 a	
volatile	 solvent	 system	 which	 carries	 the	 drug	 into	 the	 upper	 layer	 of	 the	 stratum	
corneum	prior	to	evaporation.	The	longer	the	contact	time,	the	deeper	the	penetration	






















In	 the	 case	 of	 IB	 loaded	 FFS,	 the	 drug	 permeation	was	 positively	 influenced	 by	 the	
plasticizer	concentration	(IB3)	and	the	drug	permeation	profiles	followed	the	rank	order:	
IB3>IB2>IB1	(Tukey	test,	p	<	0.01).	Since	IB	is	freely	mixable	with	EuRL	[22],	the	key	factor	
governing	 the	 extent	 of	 skin	 permeation	 in	 the	 first	 hours	 appears	 the	 solvent	
evaporation	 rate.	 Indeed,	 the	 faster	 the	 evaporation	 rate,	 the	 lower	 the	 permeated	




rate,	 showed	 no	 significant	 differences	 in	 their	 drug	 permeation	 profiles	 (One	 way	
ANOVA,	p=0.29,	Tab.	1.3),	suggesting	that	only	the	skin	barrier	properties	dictated	the	
diffusion	process.	
Aiming	 to	 investigate	 the	 effect	 of	 drug	 concentration	 on	 the	 performances	 of	 drug	
loaded	FFS,	the	formulation	FP1,	which	presented	a	“burst”	effect,	was	selected	to	carry	

































Conversely,	 the	concomitant	 increase	of	 the	applied	volume	and	the	decrease	of	 the	
drug	 concentration,	 to	 apply	 the	 same	 dose	 (see	 formulations	 FP1	 (10	 µL)	 and	 FP4	
(Tukey	test,	p	=	0.025,	Tab.	1.3),	significantly	affected	both	the	FP	flux	and	the	amount	
permeated	after	24	h.	This	might	be	attributed	to	a	lower	thermodynamic	activity	of	the	













relevance	of	 these	two	formulation	parameters	 is	strictly	 related	to	the	 loaded	drug,	
even	within	the	same	class	of	compounds	(e.g.	in	our	case	the	aryl-propionic	acids).	In	
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no	 information	 is	 available	 on	 both	 viscoelastic	 and	 adhesive	 properties	 of	 such	
compositions.	 This	 work	 focuses	 on	 the	 evaluation	 of	 both	 rheological	 and	 texture	
properties	of	EuRL	differently	plasticized	with	tributyl	citrate	(TBC)	or	triacetin	(TRI)	in	
order	 to	 design	 a	 pressure	 sensitive	 adhesive	 suitable	 for	 transdermal	 patch	
preparation.	The	patch	adhesive	properties	(i.e.	tack,	peel	adhesion	and	shear	adhesion)	
as	well	as	 its	 in	vitro	biopharmaceutical	performances	were	determined	after	 loading	
ibuprofen,	ketoprofen	or	flurbiprofen.	The	addition	of	40-60%	w/w	TBC	or	40-50%	w/w	
TRI	 to	 EuRL	 permitted	 to	 obtain	 matrices	 with	 the	 desired	 adhesive	 properties.	
Moreover,	 the	 increase	 of	 plasticizer	 content	 and	 loading	 of	 the	 drug	 reduced	 the	
relaxation	time	(tR).	Consequently,	the	shear	adhesion	values	decreased	and	the	in	vitro	
drug	release	constants	(k)	increased.	Indeed,	the	k	values	from	patches	containing	TBC	
were	 lower	 than	 the	 corresponding	 with	 TRI	 because	 of	 the	 lower	 fluidity	 of	 such	
matrices.	In	conclusion,	the	60/40	EuRL/TBC	binary	blend	is	suitable	for	the	design	of	






















over	 the	whole	delivery	 surface	 for	 the	 entire	 treatment	period.	 If	 the	patch	 lifts	 or	
partially	 detaches,	 the	 effective	 contact	 area,	 and	 thus	 the	 drug	 absorption,	 is	
unpredictable	and	therapeutic	failure	can	occur	[2].	
The	 adhesive	 properties	 of	 a	 PSA	 strongly	 depend	 on	 their	 viscoelastic	 properties.	
Viscoelastic	materials	are	needed	in	order	to	relax	stresses,	easily	create	a	molecular	
contact	and	dissipate	energy	upon	debonding.	 Indeed,	PSAs	should	be	soft	and	relax	
stresses	 to	 favor	 the	 contact	 with	 the	 substrate	 [3],	 but	 they	 should	 also	 be	 highly	
dissipative	and	lightly	physically	or	chemically	crosslinked	to	resist	to	the	applied	stress	
once	 the	 bond	 is	 formed.	 From	 a	 technological	 point	 of	 view,	 the	 PSA	 matrix	 is	
characterized	by	tack,	peel	adhesion	and	resistance	to	shear.	Tack	is	the	property	that	
enables	an	adhesive	 to	 form	a	bond	with	 the	surface	of	another	material	upon	brief	
contact	and	under	 light	pressure;	peel	adhesion	 is	 the	 force	required	to	peel	away	a	




















release	 properties	 of	 the	 optimal	 combinations	 were	 evaluated	 by	 adding	 three	
different	 drugs,	 namely	 ibuprofen,	 flurbiprofen	 and	 ketoprofen.	 PSAs	 were	
characterized	 in	 terms	 of	 rheological	 and	 tack	 properties.	 Probe	 tack	 tests	 were	
performed	 not	 only	 to	 evaluate	 the	 adhesive	 properties	 of	 the	 PSAs,	 but	mainly	 to	
understand	better	the	debonding	mechanisms	[6,7].	The	patches	were	characterized	by	














Tributyl	 citrate	 (Citroflex	 4,	 TBC)	 was	 supplied	 by	 Morflex	 (Greensboro,	 USA)	 and	
triacetin	 (TRI),	 ethyl	 acetate	 (EtOAc)	 and	 isopropanol	 (iPrOH)	 were	 purchased	 from	
Sigma	 Aldrich	 (Milan,	 Italy).	 The	 release	 liner	 used	 for	 patch	 preparation	 was	 a	
siliconized	polyester	film	from	Saint	Gobain	kindly	donated	by	Bouty	(Cassina	de	Pecchi,	
Italy),	while	the	backing	layer	was	a	polyester	film	with	a	thickness	of	57	µm	(Polifibra,	
Agrate	 Brianza,	 Italy).	 Three	 active	 ingredients	 were	 selected:	 S-ibuprofen	 (IB)	 was	
purchased	from	Dipharma	Francis	(Baranzate,	 Italy);	ketoprofen	(KP)	and	flurbiprofen	










































Attenuated	 total	 reflectance	 Fourier	 transform	 infrared	 (ATR-FTIR)	 spectra	 were	
recorded	over	the	wavenumber	region	4000-650	cm-1	with	an	ATR-FTIR	spectrometer	
(Perkin	Elmer,	Waltham,	USA),	equipped	with	a	diamond	crystal.	For	each	sample	256	












































acquired	 simultaneously.	 Since	 the	 results	 are	 influenced	 by	 the	 film	 thickness,	 the	
force-distance	curve	was	converted	into	a	stress-strain	curve.		
The	 tensile	 stress	 (s)	 was	 calculated	 by	 dividing	 the	 force	 registered	 during	 the	
detachment	(F)	for	the	contact	area	(A),	evaluated	by	the	video	streaming,	as	follows:	





























micrometer	 (ChemInstruments,	 Fairfield,	 USA).	 First,	 the	 whole	 thickness	 (TW)	 was	
















500	g	was	applied	 to	 the	 clamp	 [11].	 The	entire	 setup	was	enclosed	 in	a	 controlled-

















mm	of	 the	exposed	patch	with	 the	adhesive	side	of	 the	 tape	attached	 to	 the	one	of	







The	 average	 force	was	 calculated	 as	 the	 arithmetic	mean	 of	 all	 values	 of	 the	 linear	
portion	 of	 the	 curve.	 The	 peel	 values	 are	 expressed	 in	 centiNewton	 per	 centimeter	


























An	 exactly	 weighted	 2.54	 cm2	 patch	 sample	 was	 dissolved	 in	 20	 mL	 methanol	 by	
sonication	(UP200st,	Hielscher,	Teltow,	Germany)	and	mechanically	stirred.	Afterwards,	





























the	 use	 of	 biological	 samples	 for	 research	 purposes	 [14].	 After	 removing	 the	
subcutaneous	 fatty	 tissue,	 skin	 was	 kept	 frozen	 until	 further	 use.	 For	 the	 sample	
preparation,	adequate	pieces	of	the	frozen	skin	were	immersed	in	water	at	60	°C	for	60	




















water	 bath	 so	 that	 the	 skin	 surface	 temperature	 was	 at	 32	 ±	 1 °C	 and	 the	 receiver	
medium	was	continuously	maintained	under	stirring	with	a	magnetic	bar.		
The	experiments	(three	replicates	per	formulation)	were	performed	over	a	24	h	period	












The	 drug	 concentration	 in	 each	 patch,	 in	 the	 dissolution	media	 and	 in	 the	 receiving	
media	 were	 quantified	 by	 HPLC	 analysis	 (Agilent	 HP	 1100,	 Chemstation,	 Hewlett	
























adherent,	 to	 its	 rheological	behavior	and,	obviously,	 to	 its	adhesive	properties.	All	of	
these	 characteristics	 are	 strongly	 dependent	 on	 the	 application	 temperature.	 It	 is	
generally	 recognized	 that	 when	 the	 glass	 transition	 temperature	 (Tg)	 of	 a	 lightly	
entangled	and	high	molecular	weight	polymer	is	25	-	45	°C	lower	than	the	application	
temperature	 the	material	 becomes	 sticky	 [17].	 Since	 the	 raw	 EuRL	 exhibited	 a	 Tg	 of	







The	 rheological	analyses	 revealed	 that,	with	 the	exception	of	 form.	no.	6,	 showing	a	
distinctly	liquid	behavior	in	the	considered	frequency	range,	all	the	formulations	were	















evaluating	 the	 vertical	 shift	 in	 elastic	 and	 viscous	 moduli,	 i.e.	 G’	 and	 G’’,	 and	 the	
horizontal	shift	of	the	crossover	point.		
In	order	to	evaluate	the	structure	of	the	PSA	in	the	in-use	conditions,	the	experiments	
























































































































































































































frequency	 sweep	measurements	 at	 25	 °C	 that	 formulations	 containing	 TRI	 are	more	
























In	 this	 region,	 independently	 of	 the	PSA	 composition,	 the	 intensity	 of	 the	C=O	band	

























the	 so-called	 Dahlquist	 criterion	 of	 tackiness	with	 the	 only	 exception	 of	 form.	 no.	 1	
showing	a	slightly	higher,	but	still	acceptable,	G’	value	either	at	room	temperature	and	
skin	temperature.	












































Increasing	 the	 debonding	 rate,	 independently	 of	 the	 temperature,	 the	 maximum	
nominal	stress	and	the	work	of	adhesion	increased	significantly	(Fig.	2.8a	and	b),	at	least	
up	 to	 the	 values	 taken	 into	 consideration.	 This	 behavior	 can	 be	 attributed	 to	 the	
























they	 presented	 somewhat	 different	 rheological	 properties.	 Indeed,	 the	 debonding	
process	 was	 governed	 by	 a	 viscous	 flow,	 independently	 of	 the	 debonding	 rate	 and	
temperature.	 Four	 different	 stages	 were	 identified:	 (i)	 homogeneous	 deformation	





nucleation	 and	 rapid	 growth	 of	 voids	 at	 the	 probe-film	 interface,	 close	 to	 the	 point	
where	the	nominal	stress	goes	through	a	maximum;	(iii)	slow	growth	of	these	voids	until	
they	 occupy	most	 of	 the	 initial	 contact	 area;	 (iv)	 air	 penetration	 into	 the	 voids	 and	






































both	 cases,	 the	 peel	 adhesion	 values	 decreased	 with	 increasing	 the	 plasticizer	
concentration.	However,	the	relatively	low	peel	force	values	obtained	can	be	considered	
satisfactory,	 since	 higher	 values	 could	 cause	 pain	 or	 skin	 damage	 upon	 the	 patch	
removal.		
Cold	 flow,	 a	 phenomenon	 similar	 to	 drug	 leakage	 from	 the	 edge	 of	 membrane-
controlled	patch,	is	one	of	the	possible	product	quality	defects	[24].	It	represents	the	
migration	of	 the	PSA	outside	 the	edge	of	 the	backing	 layer	during	 the	storage	and	 it	
occurs	when	the	matrix	flows	like	a	very	viscous	liquid	between	the	backing	layer	and	
the	release	liner	during	the	storage.	As	an	example,	this	negative	effect	may	result	in	a	






obtain	 a	 positive	 answer	 to	 the	 rolling	 ball	 tack	 test	 was	 about	 35%	 and	 40%,	
respectively.	 Similarly,	 40%	 of	 di-butyl-phthalate	 was	 required.	 Indeed,	 when	 this	
plasticizer	was	used	at	lower	concentrations	(i.e.	30%	and	20%)	to	develop	transdermal	
patches	 containing	 risperidone	 [26]	 and	 verapamil	 [27],	 it	 would	 not	 be	 enough	 to	
conferee	suitable	adhesive	properties	to	the	patch.	Indeed,	since	the	patch	was	fixed	to	










casting	 on	 the	 release	 liner,	 the	 drug	 loaded	 patches	 were	 prepared	 using	 only	
isopropanol	as	solvent.	In	all	cases,	the	drug	content	complied	the	Ph.	Eur	assay	for	the	
uniformity	of	dosage	units	(Tab.	2.3).	
The	 loading	of	 the	selected	active	 ingredients,	namely	 IB,	KP	and	FP,	 to	 the	matrices	
containing	TRI	did	not	significantly	influenced	the	debonding	patterns	(data	not	shown),	
peel	 adhesion	 and	 shear	 adhesion	 values	 (Tables	 2.1	 and	 2.2).	 These	 data	 were	 in	
agreement	with	the	lack	of	modification	on	the	rheological	pattern	suggesting	that	the	
loaded	 drug	 did	 not	 modify	 the	 interactions	 occurring	 between	 EuRL	 and	 TRI.	






























































































































































































































































































flurbiprofen	 (Transactâ)	and	 ibuprofen	 (Ibupasâ)	and	slightly	 lower	with	 respect	 that	
loaded	with	ketoprofen	(Keplatâ)	[11].		
The	increased	mobility	(or	lower	viscosity)	caused	by	the	selected	drugs	did	not	have	a	








about	 4-fold	 lower	 than	 those	measured	 in	 the	 case	 of	 FP	 and	 IB,	 which	 were	 not	










The	 current	work	 allowed	defining	 the	 rheological	 and	 adhesive	properties	 of	 highly	
plasticized	 EuRL.	 The	 results	 permitted	 to	 identify	 the	 optimal	 copolymer/plasticizer	







In	 conclusion,	 the	knowledge	of	 viscoelastic	properties	of	 the	PSA	appears	 crucial	 to	
identify	the	formulation	space	during	the	development	of	transdermal	patches	and/or	
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SEBS-low	 molecular	 weight	 is	 the	 polymer	 worthy	 of	 consideration	 because	 of	 its	









polystyrene	 endblocks,	 which	 give	 characteristics	 of	 rigidity,	 and	 a	 linear	 midblock,	
which	 confers	 flexibility	 to	 the	 copolymer.	 Thus,	 they	 combine	 the	 mechanical	
properties	of	rubbers	with	the	processability	characteristics	of	thermoplastics.		
Among	these	copolymers,	styrene-isoprene-styrene	(SIS)	copolymers	were	studied	for	
the	 design	 of	 pressure	 sensitive	 adhesives	 [1]	 suitable	 for	 the	 preparation	 of	 both	
transdermal	patches	[2]	and	medical	devices	[3].	However,	because	of	their	chemical	
structure,	they	need	to	be	compounded	with	relatively	large	amount	of	antioxidants	to	
improve	 their	 stability	 [4].	 Conversely,	 styrene-block-(ethylene-co-butylene)-block-
styrene	 (SEBS)	 copolymers,	 being	 hydrogenated	 derivatives,	 are	 elastomers	 with	
outstanding	stability	to	UV	radiations	and	well-known	biocompatibility	[5,6].		
The	 compounding	 of	 SEBS	with	 paraffin	 oil	 and	 aliphatic	 resins	 (tackifiers)	 allows	 to	




Taking	 into	 account	 all	 these	 considerations,	 SEBS	 copolymers	 appear	 potential	





demonstrate	 the	 potentialities	 of	 such	 class	 of	 materials	 in	 the	 development	 of	
transdermal	patches.		
The	 adhesive	 properties	 were	 conferred	 using	 low	molecular	 weight,	 but	 high	 glass	
transition	temperature	hydrocarbon	resin	as	tackifier	and	liquid	paraffin	as	plasticizer	
[9].	In	particular,	two	resins,	with	similar	ring	and	ball	softening	point,	cloud	point	and	






average	molecular	weight	 and	 characterized	 by	 determining	 rheological	 pattern	 and	
adhesive	 properties	 focusing	 the	 attention	 on	 debonding	 behavior	 under	 different	
operative	 conditions.	 The	 in	 vitro	 biopharmaceutical	 performances	 of	 patches	 were	
assessed	using	ibuprofen	and	nicotine,	as	model	drugs.	These	compounds	were	selected	












L),	 Europrene	 SOL	 THÒ	 2312	 (three	 blocks,	 30%	 bound	 styrene,	 average	 molecular	





point	 =	 100	 °C,	 glass	 transition	 temperature	 =	 41	 °C,	 cloud	point	 =	 81	 °C,	molecular	
weight	=	1000	g/mol)	were	received	from	Eingemann&Veronelli	Spa	(Rho,	Italy).	Paraffin	
oil	was	obtained	by	Carlo	Erba	(Milan,	Italy).	In	order	to	produce	transdermal	patches	a	
polyester	 film	 was	 chosen	 as	 backing	 layer,	 while	 a	 polyester	 siliconized	 film	 Saint	
Gobain	 (thickness	 120	 µm)	 as	 release	 liner.	 S-ibuprofen	 (IB)	 and	 nicotine	 (NT)	were	
purchased	 from	Dipharma	Francis	 (Baranzate,	 Italy)	 and	 Sigma–Aldrich	 (Milan,	 Italy),	





SEBS	were	swelled	 in	 toluene	and	 the	mixtures	were	continuously	maintained	under	
stirring	 with	 a	 magnetic	 bar	 at	 room	 temperature	 for	 1	 hour.	 Then,	 the	 other	
components	 of	 the	 formulation	 were	 added	 and	 the	 mixture	 was	 continuously	
maintained	under	stirring	with	a	magnetic	bar	at	room	temperature	for	23	hours.	When	




































































































































































45	 °C	 under	 vacuum	 for	 24	hours.	 After	 7	 days,	 necessary	 for	 PSA	maturation,	 each	
sample	was	cut	(diameter:	22	mm)	by	using	a	punch.	Strain	sweep	measurements	were	













under	 vacuum	 for	 24	 hours.	 The	 PSA	 final	 thickness	was	 evaluated	 by	 a	white	 light	
scattering	 technique	 with	 an	 optical	 profilometer	 (Microsurf	 3D,	 Fogale	 nanotech).	
Probe	tack	experiments	were	performed	on	a	custom-designed	apparatus	adapted	on	a	
MTS	 810	 hydraulic	 testing	 machine,	 allowing	 the	 simultaneous	 observation	 of	 the	













and	 at	 skin	 surface	 temperature	 (32	 ±	 0.5	 °C).	 The	 whole	 force-distance	 curve	 was	
recorded.	 The	 detachment	 force	 and	 the	 elongation	 at	 break	 were	 measured	 and	




	! = 	$ %	 	 	 	 	 	 	 	 	 Eq.	3.1	









































































































was	 set	 at	 25	 rpm.	 Samples	 (5	 mL)	 were	 collected	 at	 predetermined	 intervals	 and	
assayed	 by	HPLC,	 according	 to	 the	methods	 reported	 in	 paragraph	 3.2.13.	 An	 equal	
volume	of	fresh	medium	was	immediately	added	to	maintain	the	dissolution	volume.		
The	release	rate	constant	was	calculated	according	to	Higuchi’s	equation	as	follows:	














IB-permeation	 profile	 from	 SEBS-patches.	 The	 skin	 was	 obtained	 from	 the	 ears	 of	
different	pigs,	which	were	kindly	provided	by	a	local	slaughterhouse	(Milan,	Italy).		
The	pig	ear	skin	was	separated	from	the	underlying	cartilage,	cut	into	squares	of	about	
3.5	 cm2	 and	 sealed	 in	 evacuated	 plastic	 bags	 and	 frozen	 at	 -20	 °C.	 Before	 the	
experiments,	the	samples	were	equilibrated	at	room	temperature	for	1	hour.		




















The	 cumulative	 amount	 permeated	 through	 the	 pig	 ear	 skin	 per	 unit	 of	 area	 was	
calculated	 from	 the	 concentration	 of	 IB	 in	 the	 receiving	 medium	 and	 plotted	 as	 a	








The	 IB	 and	 NT	 concentrations	 were	 quantified	 by	 HPLC	 analysis	 (Agilent	 HP	 1100,	







°C	 on	 a	 C18	 reverse-phase	 column	 (Lichrospher,	 100	 RP-18E,	 Agilent,	 G).	 The	
composition	of	the	eluent	was	2.31	g/L	sodium	dodecyl	sulphate	in	acetonitrile/	13.6	





















formulation	 the	 relaxation	 time	 (defined	as	 the	phase	angle	 inverse	at	 the	crossover	
point	 between	 the	 storage	 and	 viscous	 moduli)	 fell	 within	 the	 considered	 range	 of	
frequencies	and	resulted	0.40	and	0.13	second	at	25	and	32	 °C,	 respectively.	On	 the	
contrary,	the	storage	moduli	of	the	formulations	nos.	3	and	5	were	significantly	higher	













The	storage	 (elastic)	moduli	at	0.1	 rad/s	and	25	°C	of	 the	 formulations	composed	by	
SEBS-M	or	SEBS-H	(form.	nos.	3	and	5)	were	closed	to	6	kPa	(Tab.	3.2).	The	formulation	
prepared	 by	 SEBS-L	 showed	 significant	 lower	 G’	 values	 at	 the	 same	 frequency	 and	
temperature	(about	0.5	kPa).	The	non-significant	difference	among	the	formulations	nos	
3	and	5	(Tab.	3.2),	despite	the	polymer	molecular	weight	was	different,	is	due	to	their	








1	 SEBS-L	 RegaliteÒ	H1100	 0.51	 2.11	x	10-3	
3	 SEBS-M	 RegaliteÒ	H1100	 5.94	 6.35	x	10-3	
5	 SEBS-H	 RegaliteÒ	H1100	 6.26	 6.54	x	10-3	
 
 
In	 order	 to	 develop	 suitable	 transdermal	 patches,	 the	matrix	 viscoelasticity	 plays	 an	
important	role	to	assure	the	appropriate	balance	among	cohesion,	to	avoid	a	too	high	
creep	 compliance	 and	obtain	 an	 adequate	 shear	 adhesion,	 to	dissipate	 energy	upon	
patch	application	and	obtain	a	suitable	peel	adhesion	during	the	removal	of	the	patch	
from	 the	 skin	 [17].	 In	 other	words,	 pressure	 sensitive	 adhesive	 should	behave	 as	 an	









However,	 as	 shown	 in	 Table	 3.2,	 all	 the	 formulations	 satisfied	 Dahlquist’s	 criterion,	







Texture	experiments	were	performed	not	only	 to	 evaluate	 the	PSA	 instant	 adhesion	
properties,	but	also	its	debonding	mechanism.		
The	compression	force	(30	N)	applied	during	the	experiment	was	preliminary	evaluated	







and	 adhesion	 energy	 with	 the	 SEBS	 molecular	 weight.	 Figure	 3.2	 refers	 to	 the	
formulations	 prepared	with	 EastotacÔ	 H100W	 for	 sake	 of	 clarity	 since	 the	 selected	













































































1	 21.2	±	3.5	 37.8	±	9.3	 5	
2	 23.2	±	1.0	 38.0	±	9.0	 5	
3	 9.4	±	0.7	 26.4	±	2.6	 8	
4	 10.2	±	2.3	 25.8	±	3.3	 8	
5	 2.4	±	0.2	 48.0	±	9.7	 12	
6	 3.6	±	0.2	 48.6	±	10.3	 12	
 
 
This	 unexpected	 pattern	 can	 be	 explained	 considering	 that	 the	 patches	 detached	
adhesively	(i.e.	the	adherent	plate	was	clean	after	the	detachment);	as	a	consequence,	
the	shear	adhesion	results	can	not	be	considered	as	a	true	measure	of	the	PSAs	internal	

































The	 significant	 reduction	 (p	 <	 0.05)	 of	 the	 shear	 adhesion	 values	 correlated	 to	 the	
presence	 of	 both	 the	 selected	 drugs	 may	 be	 due	 to	 a	 reduction	 in	 the	 number	 of	
entanglements	 between	 the	 polymer	 chains,	 which	 determined	 an	 increase	 in	 the	
matrix	fluidity.	In	the	case	of	IB	such	a	reduction	of	shear	adhesion	values	resulted	much	




















7	 2.6	±	0.3	 75.8	±	9.6	 12	
8	 5.5	±	0.6	 76.0	±	11.7	 10	
9	 2.9	±	0.3	 42.3	±	2.9	 12	
10	 5.0	±	0.5	 45.0	±	3.8	 10	
11	 1.3	±	0.1	 36.4	±	10.0	 15	
12	 1.7	±	0.1	 37.0	±	10.1	 15	








The	 IB	 or	NT	 release	was	 completed	within	 7	 hours	 and	 it	 followed	Higuchi	 pattern	
independently	of	the	SEBS	and	tackifier	molecular	weight.		
The	 IB	 release	 constants	 (Tab.	 3.5),	 calculated	 according	 to	 the	 Higuchi	 model,	
highlighted	as	 the	 IB	constant	 release	rate	was	significantly	 faster	by	using	SEBS-L	as	
polymer	 (p	 <	 0.05),	 but	 it	 was	 not	 dependent	 on	 the	 tackifier,	 suggesting	 that	 the	




















7	 674.4	±	22.8	 0.44	±	0.02	 21.94	±	0.48	 465.77	±	12.83	
8	 688.8	±	11.1	 0.43	±	0.02	 23.65	±	3.78	 522.80	±	107.73	
9	 773.1	±	12.4	 0.36	±	0.01	 15.44	±	2.59	 307.43	±	53.06	
10	 734.7	±	30.3	 0.36	±	0.03	 14.39	±	2.04	 304.32	±	44.68	
11	 573.1	±	17.5	 0.33	±	0.01	 13.03	±	3.30	 243.81	±	63.08	
12	 586.5	±	5.1	 0.31	±	0.01	 13.21	±	0.86	 241.84	±	15.45	
Ibupas®	 -*	 0.35	±	0.01	 11.79	±	4.62	 227.04	±	7.98	




These	 data	 were	 in	 agreement	 with	 the	 rheological	 pattern:	 the	 higher	 the	 liquid	
character	of	 the	 formulation,	 the	 faster	 the	drug	 release	 rate.	Moreover,	 comparing	
these	data	with	 the	drug	 release	 results	obtained	by	dissolution	of	 the	commercially	
available	patch	loaded	with	IB,	namely	IbupasÒ,	the	drug	release	rate	from	form.	nos.	7,	
8	 and	 12	 resulted	 significantly	 different	 (p	<	 0.05).	 In	 particular,	 form.	 nos.	 7	 and	 8	
exhibited	faster	IB	release	rate	if	compared	to	that	of	IbupasÒ,	while	in	the	case	of	form.	
no.	12	it	resulted	slower.	
The	 release	constant	obtained	by	patches	 loaded	with	NT	confirmed	 its	capability	 to	
increase	 the	 fluidity	 of	 the	 matrix	 that	 was	 more	 effective	 if	 compared	 to	 IB.	 By	
comparing	k	values	of	formulations	nos.	8	and	13	was	confirmed	that	the	matrix	fluidity	
plays	 a	 key	 role	 in	 the	 drug	 release:	 the	 lower	 the	 viscosity	 of	 the	 PSA	 at	 a	 given	
temperature,	the	faster	the	release	rate.		





























as	 IB	 and	 NT.	 However,	 SEBS-low	 molecular	 weight	 is	 the	 polymer	 worthy	 of	
consideration	 to	 design	 transdermal	 patches	 because	 of	 its	 favorable	 viscoelastic	
behavior	 and	 its	 capability	 to	 not	 limit	 in	 vitro	 IB	 permeability	 if	 compared	 to	 the	
commercial	 reference	 product.	 The	 resin	 used	 to	 make	 the	 polymer	 sticky	 did	 not	
significantly	influence	the	rheological	behavior	and	adhesive	properties	placebo	SEBS-
matrices.	On	the	contrary,	concerning	the	drug	loaded	patches,	both	the	polymer	and	
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polymeric	 matrices	 on	 the	 adhesive	 properties	 was	 evidenced,	 reflecting	 on	
debonding	pattern	and	shear	adhesion;	furthermore,	the	impact	of	the	viscoelastic	
properties	on	the	in	vitro	drug	release	was	highlighted;		
(d)	 by	 studying	 film-forming	 systems	 and	 transdermal	 patches	 made	 of	 EuRL,	 the	



















skin	 permeation	 studies	 of	 three	 model	 drugs,	 namely	 ibuprofen,	 ketoprofen	 and	
flurbiprofen,	 allowed	 to	 evidence	 that	 both	 the	 vehicle	 evaporation	 rate	 and	 the	
thermodynamic	 activity	 of	 the	 drug	 within	 the	 film	 influenced	 the	 extent	 of	 skin	
permeation.	In	particular,	the	evaporation	rate	of	the	vehicle,	that	depends	not	only	by	








A	 series	of	 pressure-sensitive	 adhesives	made	of	 EuRL	 for	 the	design	of	 transdermal	
patches	were	formulated,	changing	the	solvent	used	to	solubilize	the	polymer	and	the	
type	and	content	of	plasticizer.	In	Chapter	2	the	effect	of	each	formulative	variable	on	
the	main	 rheological,	 adhesive	 and	 in	 vitro	 biopharmaceutical	 features	was	 studied.	
Interestingly,	 a	 relationship	 between	 the	 extent	 of	 viscoelasticity,	 the	 adhesive	
properties	and	drug	release	was	evidenced.	In	particular,	the	higher	the	liquid	character	











In	 the	 case	of	 SEBS	 (Chapter	3),	 the	 feasibility	 to	design	patches	was	demonstrated.	
Moreover,	the	effects	of	polymer	and	tackifier	molecular	weights	were	studied.	Even	if	
some	 formulations	 behaved	 as	 elastic	 materials,	 the	 relevance	 of	 studying	 the	
rheological	 behavior	 of	 a	 pressure-sensitive	 adhesive	 used	 to	 design	 a	 patch	 was	
verified.	As	a	matter	of	fact,	a	relationship	between	the	main	rheological	parameters,	
the	 adhesive	 properties	 and	 the	 in	 vitro	 biopharmaceutical	 performances	 was	
confirmed.	In	this	case,	the	higher	the	matrix	fluidity,	the	faster	the	in	vitro	drug	release	




































the	 design	 of	 patches.	 XI	 A.It.U.N,	 Meeting	 “Clinical	 experience	 and	
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